GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lipidor AB (OSTO:LIPI) » Definitions » Debt-to-Equity

Lipidor AB (OSTO:LIPI) Debt-to-Equity : 0.00 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Lipidor AB Debt-to-Equity?

Lipidor AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was kr0.00 Mil. Lipidor AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was kr0.00 Mil. Lipidor AB's Total Stockholders Equity for the quarter that ended in Dec. 2024 was kr7.72 Mil. Lipidor AB's debt to equity for the quarter that ended in Dec. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Lipidor AB's Debt-to-Equity or its related term are showing as below:

OSTO:LIPI' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.06   Med: -0.06   Max: -0.06
Current: 0.07

During the past 8 years, the highest Debt-to-Equity Ratio of Lipidor AB was -0.06. The lowest was -0.06. And the median was -0.06.

OSTO:LIPI's Debt-to-Equity is ranked better than
76.25% of 817 companies
in the Drug Manufacturers industry
Industry Median: 0.26 vs OSTO:LIPI: 0.07

Lipidor AB Debt-to-Equity Historical Data

The historical data trend for Lipidor AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipidor AB Debt-to-Equity Chart

Lipidor AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial - - - -0.06 -

Lipidor AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.27 -0.06 -0.06 - -

Competitive Comparison of Lipidor AB's Debt-to-Equity

For the Drug Manufacturers - General subindustry, Lipidor AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipidor AB's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lipidor AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Lipidor AB's Debt-to-Equity falls into.


;
;

Lipidor AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Lipidor AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Lipidor AB's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lipidor AB  (OSTO:LIPI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Lipidor AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Lipidor AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipidor AB Business Description

Traded in Other Exchanges
N/A
Address
c/o Ekonomistubben AB, Box 55931, Stockholm, SWE, 102 16
Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in the preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections, and atopic dermatitis.

Lipidor AB Headlines

No Headlines